MDS patients with excess iron are also at a higher risk of developing secondary acute myeloid leukemia due to potential correlations between hemosiderosis and genetic mutations including TET2 and ASXL1, which predispose to MDS progression [74]. Here, TET2 is linked to myelodysplastic syndrome.